Document Detail


The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.
MedLine Citation:
PMID:  20837635     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: Heart failure with normal ejection fraction (HFnEF) is an important clinical entity that remains incompletely understood. The novel biomarker growth differentiation factor 15 (GDF-15) is elevated in systolic heart failure (HFrEF) and is predictive of an adverse outcome. We investigated the clinical relevance of GDF-15 plasma levels in HFnEF.
METHODS AND RESULTS: A subgroup of patients from the ongoing DIAST-CHF observational trial, with a history of chronic heart failure (CHF) or positive Framingham criteria at presentation, was selected. Patients were classified as having either HFrEF (n=86) or HFnEF (n=142) and compared with healthy elderly controls (n=188) from the same cohort. Growth differentiation factor 15 levels in HFnEF were significantly higher than in controls and similar to those in HFrEF. In multivariate analysis, factors significantly associated with GDF-15 levels were age, sex, estimated glomerular filtration rate (eGFR), presence of HFrEF and HFnEF. Growth differentiation factor 15 correlated with multiple echocardiographic markers of diastolic function and was associated with 6 min walk test performance and SF-36 physical score on multivariate analysis in all patients. When using a classification for HFnEF that did not employ N-terminal pro brain natriuretic peptide (NT-proBNP) as a diagnostic criterion, the diagnostic properties of GDF-15 for detecting HFnEF tended to be superior to those of NT-proBNP, and a combination significantly improved diagnostic accuracy.
CONCLUSION: Growth differentiation factor 15 is elevated in HFnEF to a similar degree as in HFrEF. It is independently associated with impairment in exercise capacity and in physical components of quality of life. Diagnostic precision of GDF-15 is at least as good as that of NT-proBNP and combining both markers improves diagnostic accuracy.
Authors:
Raoul Stahrenberg; Frank Edelmann; Meinhard Mende; Anke Kockskämper; Hans-Dirk Düngen; Claus Lüers; Lutz Binder; Christoph Herrmann-Lingen; Götz Gelbrich; Gerd Hasenfuss; Burkert Pieske; Rolf Wachter
Related Documents :
16385925 - The association between nt-probnp levels, functional capacity and stage in patients wit...
1551645 - Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with ad...
1718285 - Human basophil releasability. viii. increased basophil releasability in patients with s...
20211335 - Usefulness of natriuretic peptide levels to predict mortality in adults with congenital...
22046205 - The frequency of a1298c and c677t polymorphisms of the methylentetrahydrofolate gene in...
21420185 - Assessment of the structural remodeling of the left atrium by 64-multislice cardiac ct:...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-13
Journal Detail:
Title:  European journal of heart failure     Volume:  12     ISSN:  1879-0844     ISO Abbreviation:  Eur. J. Heart Fail.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-06-02     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  100887595     Medline TA:  Eur J Heart Fail     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1309-16     Citation Subset:  IM    
Affiliation:
Department of Cardiology and Pneumology, University of Goettingen, 37075 Goettingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Biological Markers
Case-Control Studies
Exercise Test
Exercise Tolerance
Female
Glomerular Filtration Rate
Growth Differentiation Factor 15 / blood*
Health Status Indicators
Heart Failure, Systolic / pathology*,  ultrasonography
Humans
Linear Models
Male
Middle Aged
Multivariate Analysis
ROC Curve
Statistics as Topic
Statistics, Nonparametric
Stroke Volume*
Walking
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Growth Differentiation Factor 15
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is the band count useful in the diagnosis of infection? An accuracy study in critically ill patients...
Next Document:  Acute pulmonary oedema: clinical characteristics, prognostic factors, and in-hospital management.